PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 20260 citationsOpen Access

Chemotherapy-induced neuropathy (CIN) persists chronically for most individuals with breast cancer who develop the condition: A survey study

LWLise Worthen‐ChaudhariThe Ohio State UniversityMLMaryam B. LustbergYale UniversityBLBhillie D. LucianiThe Ohio State University

Key Points

  • Chemotherapy-induced neuropathy symptoms persist in about 85% of breast cancer patients treated with taxanes, leading to ongoing discomfort.
  • Chronic symptoms include both sensory issues and neuromotor dysfunction, significantly impacting patient quality of life over time.
  • Survey assessment highlighted the urgent need for effective novel interventions to alleviate these persistent symptoms in patients.
  • Findings suggest that existing treatments may be insufficient, highlighting the need for continued research and innovation in managing CIN.

Abstract

CIN symptoms persist chronically for most individuals (~ 85%) with breast cancer who develop the condition during taxane treatment. Novel interventions are needed to alleviate sensory symptoms and associated neuromotor dysfunction.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Worthen‐Chaudhari et al. (2026) studied this question.

synapsesocial.com/papers/69a75cb5c6e9836116a25cf4https://doi.org/10.21203/rs.3.rs-8594232/v1
Ask AI
Helpful
Bookmark
Share
View Full Paper